Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Astera Labs, Inc.ALAB · Entity 1853 | Director | September 01, 2026 | September 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Astera Labs, Inc.
Report date September 01, 2026 · Filed September 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy Alba Trust | 1,124,498 |
Last balance in matching sequence
After 2026-09-01 transaction · row 12
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
12 source rowsRow 1 · 2026-09-01 · Sale · Disposed 2,575 · Balance 1,271,923 F1: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 22, 2026. F2: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $276.7200 to $277.7100, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3: These shares are owned directly by Manuel Alba-Marquez in trust for Alba 2003 Living Trust (the "Alba Trust"), of which the Reporting Person and his spouse are co-trustees. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Row 2 · 2026-09-01 · Sale · Disposed 20,991 · Balance 1,250,932 F1: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 22, 2026. F4: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $277.7200 to $278.7100, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3: These shares are owned directly by Manuel Alba-Marquez in trust for Alba 2003 Living Trust (the "Alba Trust"), of which the Reporting Person and his spouse are co-trustees. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Row 3 · 2026-09-01 · Sale · Disposed 37,176 · Balance 1,213,756 F1: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 22, 2026. F5: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $278.7200 to $279.7100, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3: These shares are owned directly by Manuel Alba-Marquez in trust for Alba 2003 Living Trust (the "Alba Trust"), of which the Reporting Person and his spouse are co-trustees. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Row 4 · 2026-09-01 · Sale · Disposed 59,379 · Balance 1,154,377 F1: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 22, 2026. F6: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $279.7200 to $280.7100, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3: These shares are owned directly by Manuel Alba-Marquez in trust for Alba 2003 Living Trust (the "Alba Trust"), of which the Reporting Person and his spouse are co-trustees. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Row 5 · 2026-09-01 · Sale · Disposed 12,882 · Balance 1,141,495 F1: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 22, 2026. F7: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $280.7200 to $281.7100, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3: These shares are owned directly by Manuel Alba-Marquez in trust for Alba 2003 Living Trust (the "Alba Trust"), of which the Reporting Person and his spouse are co-trustees. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Row 6 · 2026-09-01 · Sale · Disposed 5,870 · Balance 1,135,625 F1: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 22, 2026. F8: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $281.7200 to $282.7000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3: These shares are owned directly by Manuel Alba-Marquez in trust for Alba 2003 Living Trust (the "Alba Trust"), of which the Reporting Person and his spouse are co-trustees. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Row 7 · 2026-09-01 · Sale · Disposed 3,954 · Balance 1,131,671 F1: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 22, 2026. F9: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $282.7200 to $283.7000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3: These shares are owned directly by Manuel Alba-Marquez in trust for Alba 2003 Living Trust (the "Alba Trust"), of which the Reporting Person and his spouse are co-trustees. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Row 8 · 2026-09-01 · Sale · Disposed 2,245 · Balance 1,129,426 F1: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 22, 2026. F10: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $283.7200 to $284.7100, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3: These shares are owned directly by Manuel Alba-Marquez in trust for Alba 2003 Living Trust (the "Alba Trust"), of which the Reporting Person and his spouse are co-trustees. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Row 9 · 2026-09-01 · Sale · Disposed 340 · Balance 1,129,086 F1: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 22, 2026. F11: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $284.7600 to $285.5900, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3: These shares are owned directly by Manuel Alba-Marquez in trust for Alba 2003 Living Trust (the "Alba Trust"), of which the Reporting Person and his spouse are co-trustees. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Row 10 · 2026-09-01 · Sale · Disposed 2,677 · Balance 1,126,409 F1: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 22, 2026. F12: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $286.3600 to $287.3500, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3: These shares are owned directly by Manuel Alba-Marquez in trust for Alba 2003 Living Trust (the "Alba Trust"), of which the Reporting Person and his spouse are co-trustees. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Row 11 · 2026-09-01 · Sale · Disposed 1,019 · Balance 1,125,390 F1: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 22, 2026. F13: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $287.6400 to $288.4100, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3: These shares are owned directly by Manuel Alba-Marquez in trust for Alba 2003 Living Trust (the "Alba Trust"), of which the Reporting Person and his spouse are co-trustees. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Row 12 · 2026-09-01 · Sale · Disposed 892 · Balance 1,124,498 F1: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 22, 2026. F14: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $288.9400 to $288.9900, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3: These shares are owned directly by Manuel Alba-Marquez in trust for Alba 2003 Living Trust (the "Alba Trust"), of which the Reporting Person and his spouse are co-trustees. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. |
| Common StockSEC Table I · non-derivative | IndirectBy Casa Alameda 2007, LLC | 253,863 |
Last balance in matching sequence
After 2026-09-01 transaction · row 24
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
12 source rowsRow 13 · 2026-09-01 · Sale · Disposed 568 · Balance 286,295 F1: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 22, 2026. F2: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $276.7200 to $277.7100, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F15: These shares are owned directly by Casa Alameda 2007, LLC, of which the Reporting Person is a manager. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Row 14 · 2026-09-01 · Sale · Disposed 4,618 · Balance 281,677 F1: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 22, 2026. F4: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $277.7200 to $278.7100, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F15: These shares are owned directly by Casa Alameda 2007, LLC, of which the Reporting Person is a manager. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Row 15 · 2026-09-01 · Sale · Disposed 8,179 · Balance 273,498 F1: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 22, 2026. F5: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $278.7200 to $279.7100, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F15: These shares are owned directly by Casa Alameda 2007, LLC, of which the Reporting Person is a manager. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Row 16 · 2026-09-01 · Sale · Disposed 13,070 · Balance 260,428 F1: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 22, 2026. F6: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $279.7200 to $280.7100, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F15: These shares are owned directly by Casa Alameda 2007, LLC, of which the Reporting Person is a manager. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Row 17 · 2026-09-01 · Sale · Disposed 2,835 · Balance 257,593 F1: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 22, 2026. F7: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $280.7200 to $281.7100, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F15: These shares are owned directly by Casa Alameda 2007, LLC, of which the Reporting Person is a manager. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Row 18 · 2026-09-01 · Sale · Disposed 1,288 · Balance 256,305 F1: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 22, 2026. F8: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $281.7200 to $282.7000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F15: These shares are owned directly by Casa Alameda 2007, LLC, of which the Reporting Person is a manager. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Row 19 · 2026-09-01 · Sale · Disposed 868 · Balance 255,437 F1: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 22, 2026. F9: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $282.7200 to $283.7000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F15: These shares are owned directly by Casa Alameda 2007, LLC, of which the Reporting Person is a manager. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Row 20 · 2026-09-01 · Sale · Disposed 491 · Balance 254,946 F1: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 22, 2026. F10: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $283.7200 to $284.7100, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F15: These shares are owned directly by Casa Alameda 2007, LLC, of which the Reporting Person is a manager. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Row 21 · 2026-09-01 · Sale · Disposed 74 · Balance 254,872 F1: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 22, 2026. F11: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $284.7600 to $285.5900, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F15: These shares are owned directly by Casa Alameda 2007, LLC, of which the Reporting Person is a manager. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Row 22 · 2026-09-01 · Sale · Disposed 588 · Balance 254,284 F1: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 22, 2026. F12: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $286.3600 to $287.3500, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F15: These shares are owned directly by Casa Alameda 2007, LLC, of which the Reporting Person is a manager. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Row 23 · 2026-09-01 · Sale · Disposed 225 · Balance 254,059 F1: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 22, 2026. F13: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $287.6400 to $288.4100, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F15: These shares are owned directly by Casa Alameda 2007, LLC, of which the Reporting Person is a manager. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Row 24 · 2026-09-01 · Sale · Disposed 196 · Balance 253,863 F1: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 22, 2026. F14: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $288.9400 to $288.9900, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F15: These shares are owned directly by Casa Alameda 2007, LLC, of which the Reporting Person is a manager. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. |
| Common StockSEC Table I · non-derivative | IndirectBy spouse | 5,000 |
Reported balance
Holding disclosure · report date 2026-09-01 · row 25
Holding and transaction disclosures are not merged.
1 source rowRow 25 · Balance 5,000 |
| Common StockSEC Table I · non-derivative | Direct | 2,351 |
Reported balance
Holding disclosure · report date 2026-09-01 · row 26
Holding and transaction disclosures are not merged.
1 source rowRow 26 · Balance 2,351 |
Filing footnotes · ownership attribution and instrument terms
F1: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 22, 2026.
F2: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $276.7200 to $277.7100, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3: These shares are owned directly by Manuel Alba-Marquez in trust for Alba 2003 Living Trust (the "Alba Trust"), of which the Reporting Person and his spouse are co-trustees. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
F4: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $277.7200 to $278.7100, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $278.7200 to $279.7100, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F6: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $279.7200 to $280.7100, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F7: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $280.7200 to $281.7100, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F8: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $281.7200 to $282.7000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F9: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $282.7200 to $283.7000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F10: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $283.7200 to $284.7100, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F11: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $284.7600 to $285.5900, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F12: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $286.3600 to $287.3500, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F13: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $287.6400 to $288.4100, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F14: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $288.9400 to $288.9900, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F15: These shares are owned directly by Casa Alameda 2007, LLC, of which the Reporting Person is a manager. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 01, 2026 Filed Apr 3, 2026 22:32 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 5,060 | $110.21 | $557,668.67 |
DisclosureSEC source: 0001134727-26-000002 · wk-form4_1775255550.xml · nonDerivative · entry 5 ALBA MANUEL · CIK 0001134727 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Alba Trust Disclosed balance after: 1,427,085 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 29, 2025. F7 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $109.8500 to $110.8300, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are owned directly by Manuel Alba-Marquez in trust for Alba 2003 Living Trust (the "Alba Trust"), of which the Reporting Person and his spouse are co-trustees. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| April 01, 2026 Filed Apr 3, 2026 22:32 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 15,367 | $109.10 | $1,676,581.19 |
DisclosureSEC source: 0001134727-26-000002 · wk-form4_1775255550.xml · nonDerivative · entry 4 ALBA MANUEL · CIK 0001134727 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Alba Trust Disclosed balance after: 1,432,145 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 29, 2025. F6 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $108.8500 to $109.8400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are owned directly by Manuel Alba-Marquez in trust for Alba 2003 Living Trust (the "Alba Trust"), of which the Reporting Person and his spouse are co-trustees. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| April 01, 2026 Filed Apr 3, 2026 22:32 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 45,668 | $108.33 | $4,947,324.04 |
DisclosureSEC source: 0001134727-26-000002 · wk-form4_1775255550.xml · nonDerivative · entry 3 ALBA MANUEL · CIK 0001134727 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Alba Trust Disclosed balance after: 1,447,512 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 29, 2025. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $107.8500 to $108.8400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are owned directly by Manuel Alba-Marquez in trust for Alba 2003 Living Trust (the "Alba Trust"), of which the Reporting Person and his spouse are co-trustees. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| April 01, 2026 Filed Apr 3, 2026 22:32 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 24,317 | $107.44 | $2,612,723.04 |
DisclosureSEC source: 0001134727-26-000002 · wk-form4_1775255550.xml · nonDerivative · entry 2 ALBA MANUEL · CIK 0001134727 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Alba Trust Disclosed balance after: 1,493,180 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 29, 2025. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $106.8500 to $107.8400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are owned directly by Manuel Alba-Marquez in trust for Alba 2003 Living Trust (the "Alba Trust"), of which the Reporting Person and his spouse are co-trustees. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| April 01, 2026 Filed Apr 3, 2026 22:32 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 57,001 | $106.32 | $6,060,312.12 |
DisclosureSEC source: 0001134727-26-000002 · wk-form4_1775255550.xml · nonDerivative · entry 1 ALBA MANUEL · CIK 0001134727 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Alba Trust Disclosed balance after: 1,517,497 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 29, 2025. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $105.8500 to $106.8400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are owned directly by Manuel Alba-Marquez in trust for Alba 2003 Living Trust (the "Alba Trust"), of which the Reporting Person and his spouse are co-trustees. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| December 01, 2025 Filed Dec 4, 2025 00:34 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 1,388 | $172.57 | $239,533.68 |
DisclosureSEC source: 0001134727-25-000007 · wk-form4_1764808440.xml · nonDerivative · entry 19 ALBA MANUEL · CIK 0001134727 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Casa Alameda 2007, LLC Disclosed balance after: 352,863 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 29, 2025. F21 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $172.1400 to $173.0700, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are owned directly by Casa Alameda 2007, LLC, of which the Reporting Person is a manager. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| December 01, 2025 Filed Dec 4, 2025 00:34 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 2,680 | $171.57 | $459,820.73 |
DisclosureSEC source: 0001134727-25-000007 · wk-form4_1764808440.xml · nonDerivative · entry 18 ALBA MANUEL · CIK 0001134727 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Casa Alameda 2007, LLC Disclosed balance after: 354,251 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 29, 2025. F20 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $171.1400 to $172.1300, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are owned directly by Casa Alameda 2007, LLC, of which the Reporting Person is a manager. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| December 01, 2025 Filed Dec 4, 2025 00:34 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 3,019 | $170.63 | $515,123.82 |
DisclosureSEC source: 0001134727-25-000007 · wk-form4_1764808440.xml · nonDerivative · entry 17 ALBA MANUEL · CIK 0001134727 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Casa Alameda 2007, LLC Disclosed balance after: 356,931 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 29, 2025. F19 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $170.1400 to $171.1300, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are owned directly by Casa Alameda 2007, LLC, of which the Reporting Person is a manager. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| December 01, 2025 Filed Dec 4, 2025 00:34 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 1,952 | $169.84 | $331,537.24 |
DisclosureSEC source: 0001134727-25-000007 · wk-form4_1764808440.xml · nonDerivative · entry 16 ALBA MANUEL · CIK 0001134727 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Casa Alameda 2007, LLC Disclosed balance after: 359,950 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 29, 2025. F18 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $169.1400 to $170.1300, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are owned directly by Casa Alameda 2007, LLC, of which the Reporting Person is a manager. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| December 01, 2025 Filed Dec 4, 2025 00:34 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 1,008 | $168.57 | $169,915.94 |
DisclosureSEC source: 0001134727-25-000007 · wk-form4_1764808440.xml · nonDerivative · entry 15 ALBA MANUEL · CIK 0001134727 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Casa Alameda 2007, LLC Disclosed balance after: 361,902 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 29, 2025. F17 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $168.1300 to $169.1200, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are owned directly by Casa Alameda 2007, LLC, of which the Reporting Person is a manager. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| December 01, 2025 Filed Dec 4, 2025 00:34 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 2,455 | $167.52 | $411,268.72 |
DisclosureSEC source: 0001134727-25-000007 · wk-form4_1764808440.xml · nonDerivative · entry 14 ALBA MANUEL · CIK 0001134727 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Casa Alameda 2007, LLC Disclosed balance after: 362,910 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 29, 2025. F16 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $167.1300 to $168.1200, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are owned directly by Casa Alameda 2007, LLC, of which the Reporting Person is a manager. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| December 01, 2025 Filed Dec 4, 2025 00:34 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 2,831 | $166.67 | $471,835.41 |
DisclosureSEC source: 0001134727-25-000007 · wk-form4_1764808440.xml · nonDerivative · entry 13 ALBA MANUEL · CIK 0001134727 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Casa Alameda 2007, LLC Disclosed balance after: 365,365 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 29, 2025. F15 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $166.1300 to $167.1100, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are owned directly by Casa Alameda 2007, LLC, of which the Reporting Person is a manager. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| December 01, 2025 Filed Dec 4, 2025 00:34 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 8,502 | $165.39 | $1,406,185.74 |
DisclosureSEC source: 0001134727-25-000007 · wk-form4_1764808440.xml · nonDerivative · entry 12 ALBA MANUEL · CIK 0001134727 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Casa Alameda 2007, LLC Disclosed balance after: 368,196 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 29, 2025. F14 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $165.1300 to $166.1200, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are owned directly by Casa Alameda 2007, LLC, of which the Reporting Person is a manager. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| December 01, 2025 Filed Dec 4, 2025 00:34 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 2,742 | $164.60 | $451,338.41 |
DisclosureSEC source: 0001134727-25-000007 · wk-form4_1764808440.xml · nonDerivative · entry 11 ALBA MANUEL · CIK 0001134727 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Casa Alameda 2007, LLC Disclosed balance after: 376,698 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 29, 2025. F13 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $164.1300 to $165.1200, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are owned directly by Casa Alameda 2007, LLC, of which the Reporting Person is a manager. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| December 01, 2025 Filed Dec 4, 2025 00:34 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 2,362 | $163.68 | $386,605.55 |
DisclosureSEC source: 0001134727-25-000007 · wk-form4_1764808440.xml · nonDerivative · entry 10 ALBA MANUEL · CIK 0001134727 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Casa Alameda 2007, LLC Disclosed balance after: 379,440 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 29, 2025. F12 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $163.1100 to $164.1000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are owned directly by Casa Alameda 2007, LLC, of which the Reporting Person is a manager. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| December 01, 2025 Filed Dec 4, 2025 00:34 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 510 | $162.52 | $82,886.17 |
DisclosureSEC source: 0001134727-25-000007 · wk-form4_1764808440.xml · nonDerivative · entry 9 ALBA MANUEL · CIK 0001134727 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Casa Alameda 2007, LLC Disclosed balance after: 381,802 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 29, 2025. F11 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $162.1100 to $163.1000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are owned directly by Casa Alameda 2007, LLC, of which the Reporting Person is a manager. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| December 01, 2025 Filed Dec 4, 2025 00:34 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 897 | $161.63 | $144,982.47 |
DisclosureSEC source: 0001134727-25-000007 · wk-form4_1764808440.xml · nonDerivative · entry 8 ALBA MANUEL · CIK 0001134727 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Casa Alameda 2007, LLC Disclosed balance after: 382,312 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 29, 2025. F10 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $161.0600 to $162.0500, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are owned directly by Casa Alameda 2007, LLC, of which the Reporting Person is a manager. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| December 01, 2025 Filed Dec 4, 2025 00:34 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 235 | $160.54 | $37,726.69 |
DisclosureSEC source: 0001134727-25-000007 · wk-form4_1764808440.xml · nonDerivative · entry 7 ALBA MANUEL · CIK 0001134727 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Casa Alameda 2007, LLC Disclosed balance after: 383,209 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 29, 2025. F9 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $160.0600 to $161.0400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are owned directly by Casa Alameda 2007, LLC, of which the Reporting Person is a manager. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| December 01, 2025 Filed Dec 4, 2025 00:34 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 212 | $159.29 | $33,770.12 |
DisclosureSEC source: 0001134727-25-000007 · wk-form4_1764808440.xml · nonDerivative · entry 6 ALBA MANUEL · CIK 0001134727 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Casa Alameda 2007, LLC Disclosed balance after: 383,444 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 29, 2025. F8 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $158.9100 to $159.8900, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are owned directly by Casa Alameda 2007, LLC, of which the Reporting Person is a manager. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| December 01, 2025 Filed Dec 4, 2025 00:34 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 93 | $158.11 | $14,704.16 |
DisclosureSEC source: 0001134727-25-000007 · wk-form4_1764808440.xml · nonDerivative · entry 5 ALBA MANUEL · CIK 0001134727 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Casa Alameda 2007, LLC Disclosed balance after: 383,656 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 29, 2025. F7 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $157.7700 to $158.3400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are owned directly by Casa Alameda 2007, LLC, of which the Reporting Person is a manager. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| December 01, 2025 Filed Dec 4, 2025 00:34 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 178 | $156.88 | $27,924.34 |
DisclosureSEC source: 0001134727-25-000007 · wk-form4_1764808440.xml · nonDerivative · entry 4 ALBA MANUEL · CIK 0001134727 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Casa Alameda 2007, LLC Disclosed balance after: 383,749 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 29, 2025. F6 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $156.3900 to $157.3800, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are owned directly by Casa Alameda 2007, LLC, of which the Reporting Person is a manager. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| December 01, 2025 Filed Dec 4, 2025 00:34 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 234 | $155.50 | $36,386.37 |
DisclosureSEC source: 0001134727-25-000007 · wk-form4_1764808440.xml · nonDerivative · entry 3 ALBA MANUEL · CIK 0001134727 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Casa Alameda 2007, LLC Disclosed balance after: 383,927 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 29, 2025. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $155.3300 to $156.0500, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are owned directly by Casa Alameda 2007, LLC, of which the Reporting Person is a manager. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| December 01, 2025 Filed Dec 4, 2025 00:34 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 711 | $154.74 | $110,023.48 |
DisclosureSEC source: 0001134727-25-000007 · wk-form4_1764808440.xml · nonDerivative · entry 2 ALBA MANUEL · CIK 0001134727 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Casa Alameda 2007, LLC Disclosed balance after: 384,161 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 29, 2025. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $154.2300 to $155.2000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are owned directly by Casa Alameda 2007, LLC, of which the Reporting Person is a manager. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| December 01, 2025 Filed Dec 4, 2025 00:34 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 991 | $153.80 | $152,411.54 |
DisclosureSEC source: 0001134727-25-000007 · wk-form4_1764808440.xml · nonDerivative · entry 1 ALBA MANUEL · CIK 0001134727 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Casa Alameda 2007, LLC Disclosed balance after: 384,872 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 29, 2025. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $153.0700 to $154.0500, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are owned directly by Casa Alameda 2007, LLC, of which the Reporting Person is a manager. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| December 01, 2025 Filed Dec 4, 2025 00:32 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 6,309 | $172.58 | $1,088,775.68 |
DisclosureSEC source: 0001134727-25-000006 · wk-form4_1764808355.xml · nonDerivative · entry 19 ALBA MANUEL · CIK 0001134727 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Alba Trust Disclosed balance after: 1,574,498 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 29, 2025. F21 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $172.1400 to $173.0700, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are owned directly by Manuel Alba-Marquez in trust for Alba 2003 Living Trust (the "Alba Trust"), of which the Reporting Person and his spouse are co-trustees. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| December 01, 2025 Filed Dec 4, 2025 00:32 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 12,186 | $171.57 | $2,090,811.73 |
DisclosureSEC source: 0001134727-25-000006 · wk-form4_1764808355.xml · nonDerivative · entry 18 ALBA MANUEL · CIK 0001134727 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Alba Trust Disclosed balance after: 1,580,807 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 29, 2025. F20 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $171.1400 to $172.1300, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are owned directly by Manuel Alba-Marquez in trust for Alba 2003 Living Trust (the "Alba Trust"), of which the Reporting Person and his spouse are co-trustees. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| December 01, 2025 Filed Dec 4, 2025 00:32 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 13,722 | $170.63 | $2,341,346.44 |
DisclosureSEC source: 0001134727-25-000006 · wk-form4_1764808355.xml · nonDerivative · entry 17 ALBA MANUEL · CIK 0001134727 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Alba Trust Disclosed balance after: 1,592,993 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 29, 2025. F19 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $170.1400 to $171.1300, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are owned directly by Manuel Alba-Marquez in trust for Alba 2003 Living Trust (the "Alba Trust"), of which the Reporting Person and his spouse are co-trustees. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| December 01, 2025 Filed Dec 4, 2025 00:32 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 8,872 | $169.84 | $1,506,863.07 |
DisclosureSEC source: 0001134727-25-000006 · wk-form4_1764808355.xml · nonDerivative · entry 16 ALBA MANUEL · CIK 0001134727 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Alba Trust Disclosed balance after: 1,606,715 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 29, 2025. F18 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $169.1400 to $170.1300, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are owned directly by Manuel Alba-Marquez in trust for Alba 2003 Living Trust (the "Alba Trust"), of which the Reporting Person and his spouse are co-trustees. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| December 01, 2025 Filed Dec 4, 2025 00:32 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 4,582 | $168.57 | $772,375.37 |
DisclosureSEC source: 0001134727-25-000006 · wk-form4_1764808355.xml · nonDerivative · entry 15 ALBA MANUEL · CIK 0001134727 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Alba Trust Disclosed balance after: 1,615,587 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 29, 2025. F17 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $168.1300 to $169.1200, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are owned directly by Manuel Alba-Marquez in trust for Alba 2003 Living Trust (the "Alba Trust"), of which the Reporting Person and his spouse are co-trustees. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| December 01, 2025 Filed Dec 4, 2025 00:32 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 11,158 | $167.52 | $1,869,219.40 |
DisclosureSEC source: 0001134727-25-000006 · wk-form4_1764808355.xml · nonDerivative · entry 14 ALBA MANUEL · CIK 0001134727 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Alba Trust Disclosed balance after: 1,620,169 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 29, 2025. F16 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $167.1300 to $168.1200, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are owned directly by Manuel Alba-Marquez in trust for Alba 2003 Living Trust (the "Alba Trust"), of which the Reporting Person and his spouse are co-trustees. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| December 01, 2025 Filed Dec 4, 2025 00:32 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 12,868 | $166.67 | $2,144,676.10 |
DisclosureSEC source: 0001134727-25-000006 · wk-form4_1764808355.xml · nonDerivative · entry 13 ALBA MANUEL · CIK 0001134727 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Alba Trust Disclosed balance after: 1,631,327 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 29, 2025. F15 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $166.1300 to $167.1100, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are owned directly by Manuel Alba-Marquez in trust for Alba 2003 Living Trust (the "Alba Trust"), of which the Reporting Person and his spouse are co-trustees. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| December 01, 2025 Filed Dec 4, 2025 00:32 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 38,644 | $165.39 | $6,391,512.79 |
DisclosureSEC source: 0001134727-25-000006 · wk-form4_1764808355.xml · nonDerivative · entry 12 ALBA MANUEL · CIK 0001134727 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Alba Trust Disclosed balance after: 1,644,195 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 29, 2025. F14 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $165.1300 to $166.1200, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are owned directly by Manuel Alba-Marquez in trust for Alba 2003 Living Trust (the "Alba Trust"), of which the Reporting Person and his spouse are co-trustees. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| December 01, 2025 Filed Dec 4, 2025 00:32 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 12,468 | $164.60 | $2,052,256.49 |
DisclosureSEC source: 0001134727-25-000006 · wk-form4_1764808355.xml · nonDerivative · entry 11 ALBA MANUEL · CIK 0001134727 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Alba Trust Disclosed balance after: 1,682,839 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 29, 2025. F13 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $164.1300 to $165.1200, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are owned directly by Manuel Alba-Marquez in trust for Alba 2003 Living Trust (the "Alba Trust"), of which the Reporting Person and his spouse are co-trustees. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| December 01, 2025 Filed Dec 4, 2025 00:32 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 10,732 | $163.68 | $1,756,583.71 |
DisclosureSEC source: 0001134727-25-000006 · wk-form4_1764808355.xml · nonDerivative · entry 10 ALBA MANUEL · CIK 0001134727 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Alba Trust Disclosed balance after: 1,695,307 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 29, 2025. F12 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $163.1100 to $164.1000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are owned directly by Manuel Alba-Marquez in trust for Alba 2003 Living Trust (the "Alba Trust"), of which the Reporting Person and his spouse are co-trustees. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| December 01, 2025 Filed Dec 4, 2025 00:32 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 2,322 | $162.52 | $377,375.39 |
DisclosureSEC source: 0001134727-25-000006 · wk-form4_1764808355.xml · nonDerivative · entry 9 ALBA MANUEL · CIK 0001134727 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Alba Trust Disclosed balance after: 1,706,039 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 29, 2025. F11 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $162.1100 to $163.1000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are owned directly by Manuel Alba-Marquez in trust for Alba 2003 Living Trust (the "Alba Trust"), of which the Reporting Person and his spouse are co-trustees. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| December 01, 2025 Filed Dec 4, 2025 00:32 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 4,076 | $161.63 | $658,803.88 |
DisclosureSEC source: 0001134727-25-000006 · wk-form4_1764808355.xml · nonDerivative · entry 8 ALBA MANUEL · CIK 0001134727 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Alba Trust Disclosed balance after: 1,708,361 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 29, 2025. F10 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $161.0600 to $162.0500, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are owned directly by Manuel Alba-Marquez in trust for Alba 2003 Living Trust (the "Alba Trust"), of which the Reporting Person and his spouse are co-trustees. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| December 01, 2025 Filed Dec 4, 2025 00:32 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 1,068 | $160.54 | $171,455.01 |
DisclosureSEC source: 0001134727-25-000006 · wk-form4_1764808355.xml · nonDerivative · entry 7 ALBA MANUEL · CIK 0001134727 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Alba Trust Disclosed balance after: 1,712,437 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 29, 2025. F9 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $160.0600 to $161.0400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are owned directly by Manuel Alba-Marquez in trust for Alba 2003 Living Trust (the "Alba Trust"), of which the Reporting Person and his spouse are co-trustees. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| December 01, 2025 Filed Dec 4, 2025 00:32 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 963 | $159.29 | $153,398.97 |
DisclosureSEC source: 0001134727-25-000006 · wk-form4_1764808355.xml · nonDerivative · entry 6 ALBA MANUEL · CIK 0001134727 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Alba Trust Disclosed balance after: 1,713,505 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 29, 2025. F8 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $158.9100 to $159.8900, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are owned directly by Manuel Alba-Marquez in trust for Alba 2003 Living Trust (the "Alba Trust"), of which the Reporting Person and his spouse are co-trustees. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| December 01, 2025 Filed Dec 4, 2025 00:32 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 425 | $158.11 | $67,195.90 |
DisclosureSEC source: 0001134727-25-000006 · wk-form4_1764808355.xml · nonDerivative · entry 5 ALBA MANUEL · CIK 0001134727 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Alba Trust Disclosed balance after: 1,714,468 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 29, 2025. F7 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $157.7700 to $158.3400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are owned directly by Manuel Alba-Marquez in trust for Alba 2003 Living Trust (the "Alba Trust"), of which the Reporting Person and his spouse are co-trustees. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| December 01, 2025 Filed Dec 4, 2025 00:32 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 807 | $156.88 | $126,599.50 |
DisclosureSEC source: 0001134727-25-000006 · wk-form4_1764808355.xml · nonDerivative · entry 4 ALBA MANUEL · CIK 0001134727 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Alba Trust Disclosed balance after: 1,714,893 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 29, 2025. F6 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $156.3900 to $157.3800, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are owned directly by Manuel Alba-Marquez in trust for Alba 2003 Living Trust (the "Alba Trust"), of which the Reporting Person and his spouse are co-trustees. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| December 01, 2025 Filed Dec 4, 2025 00:32 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 1,062 | $155.50 | $165,138.77 |
DisclosureSEC source: 0001134727-25-000006 · wk-form4_1764808355.xml · nonDerivative · entry 3 ALBA MANUEL · CIK 0001134727 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Alba Trust Disclosed balance after: 1,715,700 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 29, 2025. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $155.3300 to $156.0500, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are owned directly by Manuel Alba-Marquez in trust for Alba 2003 Living Trust (the "Alba Trust"), of which the Reporting Person and his spouse are co-trustees. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| December 01, 2025 Filed Dec 4, 2025 00:32 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 3,232 | $154.74 | $500,135.52 |
DisclosureSEC source: 0001134727-25-000006 · wk-form4_1764808355.xml · nonDerivative · entry 2 ALBA MANUEL · CIK 0001134727 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Alba Trust Disclosed balance after: 1,716,762 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 29, 2025. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $154.2300 to $155.2000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are owned directly by Manuel Alba-Marquez in trust for Alba 2003 Living Trust (the "Alba Trust"), of which the Reporting Person and his spouse are co-trustees. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| December 01, 2025 Filed Dec 4, 2025 00:32 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 4,504 | $153.80 | $692,697.63 |
DisclosureSEC source: 0001134727-25-000006 · wk-form4_1764808355.xml · nonDerivative · entry 1 ALBA MANUEL · CIK 0001134727 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Alba Trust Disclosed balance after: 1,719,994 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 29, 2025. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $153.0700 to $154.0500, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are owned directly by Manuel Alba-Marquez in trust for Alba 2003 Living Trust (the "Alba Trust"), of which the Reporting Person and his spouse are co-trustees. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| September 02, 2025 Filed Sep 4, 2025 23:08 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 569 | $180.10 | $102,476.22 |
DisclosureSEC source: 0001736297-25-000129 · wk-form4_1757027294.xml · nonDerivative · entry 26 ALBA MANUEL · CIK 0001134727 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Casa Alameda 2007, LLC Disclosed balance after: 385,863 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 29, 2025. F15 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $179.7800 to $180.5300, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F16 · ownership.nature: These shares are owned directly by Casa Alameda 2007, LLC, of which the Reporting Person is a manager. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| September 02, 2025 Filed Sep 4, 2025 23:08 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 718 | $179.25 | $128,698.77 |
DisclosureSEC source: 0001736297-25-000129 · wk-form4_1757027294.xml · nonDerivative · entry 25 ALBA MANUEL · CIK 0001134727 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Casa Alameda 2007, LLC Disclosed balance after: 386,432 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 29, 2025. F14 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $178.7600 to $179.7400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F16 · ownership.nature: These shares are owned directly by Casa Alameda 2007, LLC, of which the Reporting Person is a manager. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| September 02, 2025 Filed Sep 4, 2025 23:08 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 411 | $178.22 | $73,246.73 |
DisclosureSEC source: 0001736297-25-000129 · wk-form4_1757027294.xml · nonDerivative · entry 24 ALBA MANUEL · CIK 0001134727 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Casa Alameda 2007, LLC Disclosed balance after: 387,150 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 29, 2025. F18 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $177.7100 to $178.6700, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F16 · ownership.nature: These shares are owned directly by Casa Alameda 2007, LLC, of which the Reporting Person is a manager. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| September 02, 2025 Filed Sep 4, 2025 23:08 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 2,965 | $177.03 | $524,901.36 |
DisclosureSEC source: 0001736297-25-000129 · wk-form4_1757027294.xml · nonDerivative · entry 23 ALBA MANUEL · CIK 0001134727 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Casa Alameda 2007, LLC Disclosed balance after: 387,561 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 29, 2025. F12 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $176.6000 to $177.5800, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F16 · ownership.nature: These shares are owned directly by Casa Alameda 2007, LLC, of which the Reporting Person is a manager. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| September 02, 2025 Filed Sep 4, 2025 23:08 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 2,116 | $176.23 | $372,907.97 |
DisclosureSEC source: 0001736297-25-000129 · wk-form4_1757027294.xml · nonDerivative · entry 22 ALBA MANUEL · CIK 0001134727 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Casa Alameda 2007, LLC Disclosed balance after: 390,526 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 29, 2025. F11 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $175.6100 to $176.5900, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F16 · ownership.nature: These shares are owned directly by Casa Alameda 2007, LLC, of which the Reporting Person is a manager. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| September 02, 2025 Filed Sep 4, 2025 23:08 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 882 | $175.04 | $154,387.31 |
DisclosureSEC source: 0001736297-25-000129 · wk-form4_1757027294.xml · nonDerivative · entry 21 ALBA MANUEL · CIK 0001134727 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Casa Alameda 2007, LLC Disclosed balance after: 392,642 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 29, 2025. F17 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $174.6000 to $175.5700, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F16 · ownership.nature: These shares are owned directly by Casa Alameda 2007, LLC, of which the Reporting Person is a manager. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| September 02, 2025 Filed Sep 4, 2025 23:08 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 7,983 | $174.02 | $1,389,185.69 |
DisclosureSEC source: 0001736297-25-000129 · wk-form4_1757027294.xml · nonDerivative · entry 20 ALBA MANUEL · CIK 0001134727 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Casa Alameda 2007, LLC Disclosed balance after: 393,524 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 29, 2025. F9 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $173.5900 to $174.5700, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F16 · ownership.nature: These shares are owned directly by Casa Alameda 2007, LLC, of which the Reporting Person is a manager. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.